FDA Inspection
Zhejiang Langhua Pharmaceutical Co. Ltd.Zhejiang Langhua Pharmaceutical Co. Ltd. – FDA Inspection, Aug 30, 2024
Record Details
This FDA Inspection record concerns Zhejiang Langhua Pharmaceutical Co. Ltd., with an inspection on August 30, 2024, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · b21ab25a-1b58-4d2a-b235-eee5dd933e10
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1250797
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Zhejiang Langhua Pharmaceutical Co. Ltd.
3| Date | Classification | Office | Project area |
|---|---|---|---|
| March 23, 2018 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 21, 2014 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 1, 2012 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Zhejiang Langhua Pharmaceutical Co. Ltd.
- FDA Inspection 1049002 - 2018-03-23
- FDA Inspection 906650 - 2014-11-21
- FDA Inspection 774858 - 2012-03-01
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.